Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.

T Gerotziafas, Grigoris; Catalano, Mariella; Colgan, Mary-Paula; Pecsvarady, Zsolt; Claude Wautrecht, Jean; Fazeli, Bahare; Olinic, Dan-Mircea; Farkas, Katalin; Elalamy, Ismail; Falanga, Anna; Fareed, Jawed; Papageorgiou, Chryssa; S Arellano, Rosella; Agathagelou, Petros; Antic, Darco; Auad, Luciana; Banfic, Ljiljana; R Bartolomew, John; Benczur, Bela; B Bernardo, Melissa; Boccardo, Francesco; Cifkova, Renate; Cosmi, Benilde; De Marchi, Sergio; Dimakakos, Evangelos; A Dimopoulos, Meletios; Dimitrov, Gabriel; Durand-Zaleski, Isabelle; Edmonds, Michael; Abo El Nazar, Essam; Erer, Dilek; L Esponda, Omar; Gresele, Paolo; Gschwandtner, Michael; Gu, Yongquan; Heinzmann, Mónica; M Hamburg, Naomi; Hamadé, Amer; Jatoi, Noor-Ahmed; Karahan, Oguz; Karetova, Debora; Karplus, Thomas; Klein-Weigel, Peter; Kolossvary, Endre; Kozak, Matija; Lefkou, Eleftheria; Lessiani, Gianfranco; Liew, Aaron; Marcoccia, Antonella; Marshang, Peter

doi:10.1055/s-0040-1715798

Public

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.

Published in Thrombosis and haemostasis • Dec 1, 2020

NobleIDark:/48914/w1/20260526/9835E223Record on NobleID

Authors:

Grigoris T Gerotziafas

,

Mariella Catalano

,

Mary-Paula Colgan

Abstract

COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis. Predisposing risk factors to severe COVID-19 are male sex, underlying cardiovascular disease, or cardiovascular risk factors including n...

Discussions